Track the Demant A/S share price and the full insider trade history of the company, a listed issuer based in Denmark. Shares are listed on DK DK, under the supervision of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Demant A/S has published 39 reports. Market capitalisation: €58.2bn. The latest transaction was reported on 7 April 2026 (Grant). Among the most active insiders: Unknown. All data is free.
39
Insider Decl.
0
Thresholds
€125m
10 ops.
Buy Volume
€5m
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Demant A/S Buy (bullish), based on 20 analysts. Average price target: DKK 260.65.
20Σ signal
Buys €125m€5m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,855 of 25,956 companies
58.0
score / 100
Value
50
Quality
66
FCF yld5.2%
Earn yld2.7%
EV/EBITDA15.1x
ROE24%
Gross mgn76%
Net mgn6.7%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Demant A/S is a Danish company specializing in hearing solutions and communication technologies. It provides products and services to enhance the hearing and quality of life for individuals with hearing impairments.